Publikationen, an denen er mitarbeitet Marta Concheiro Guisán (38)

2022

  1. Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry

    Journal of analytical toxicology, Vol. 46, Núm. 8, pp. 852-859

2021

  1. Assessment of biological matrices for the detection of in utero cannabis exposure

    Drug Testing and Analysis, Vol. 13, Núm. 7, pp. 1371-1382

  2. Quantification of Classic, Prescription and Synthetic Opioids in Hair by LC-MS-MS

    Journal of Analytical Toxicology, Vol. 45, Núm. 9, pp. 943-949

2020

  1. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy

    Journal of Addictive Diseases, Vol. 39, Núm. 2, pp. 175-182

  2. LC-MS-MS Method for the Determination of Antidepressants and Benzodiazepines in Meconium

    Journal of analytical toxicology, Vol. 44, Núm. 6, pp. 580-588

2019

  1. A LC-MS/MS method for the determination of common synthetic cathinones in meconium

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1124, pp. 349-355

  2. Detection of in utero ethanol exposure via ethyl glucuronide and ethyl sulfate analysis in umbilical cord and placenta

    Forensic Toxicology, Vol. 37, Núm. 1, pp. 90-103

2018

  1. Detection of in utero cannabis exposure by umbilical cord analysis

    Drug Testing and Analysis, Vol. 10, Núm. 4, pp. 636-643

  2. Development and validation of a liquid chromatography–tandem mass spectrometry method for the determination of nicotine and its metabolites in placenta and umbilical cord

    Drug Testing and Analysis, Vol. 10, Núm. 8, pp. 1305-1314

2017

  1. ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy

    Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474

  2. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy

    Drug Testing and Analysis, Vol. 9, Núm. 6, pp. 898-904

  3. Development and validation of a liquid chromatography tandem mass spectrometry method for the determination of cannabinoids and phase I and II metabolites in meconium

    Journal of Chromatography A, Vol. 1497, pp. 118-126

2014

  1. Bioanalysis during pregnancy: Recent advances and novel sampling strategies

    Bioanalysis, Vol. 6, Núm. 23, pp. 3133-3153

2013

  1. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection

    Therapeutic Drug Monitoring, Vol. 35, Núm. 4, pp. 502-509

  2. Maternal hair analysis for the detection of illicit drugs, medicines, and alcohol exposure during pregnancy

    Therapeutic Drug Monitoring, Vol. 35, Núm. 3, pp. 296-304

  3. Simultaneous determination of opiates, methadone, amphetamines, cocaine, and metabolites in human placenta and umbilical cord by LC-MS/MS

    Analytical and Bioanalytical Chemistry, Vol. 405, Núm. 12, pp. 4295-4305

  4. Simultaneous quantification of δ9-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry

    Journal of Chromatography A, Vol. 1297, pp. 123-130

2012

  1. Hair analysis interpretation of an unusual case of alleged scopolamine-facilitated sexual assault

    Forensic Toxicology, Vol. 30, Núm. 2, pp. 193-198

  2. Target screening and confirmation of 35 licit and illicit drugs and metabolites in hair by LC-MSMS

    Forensic Science International, Vol. 217, Núm. 1-3, pp. 207-215

2009

  1. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, Núm. 27, pp. 3065-3071